INSTANTPEPTIDES

Snap-8: Acetyl Octapeptide-3 Research Overview

Snap-8, also designated Acetyl Octapeptide-3 or Argireline derivative, is a synthetic 8-amino acid peptide designed to mimic a region of SNAP-25, a key component of the SNARE protein complex that mediates neurotransmitter vesicle fusion. The compound is widely studied in cosmetic chemistry research as a botulinum-mimetic agent. This page summarizes the published preclinical literature.

Last reviewed: 2026-05-11· Instant Peptides Research Team
Research-use reference only. The content below summarizes published preclinical and in vitro research. Not for human or animal consumption, diagnostic, or therapeutic use. Information is provided as an educational resource for qualified research professionals.

Background

SNARE proteins (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptors) are a family of cellular proteins responsible for mediating vesicle fusion with target membranes. In neurons, the SNARE complex consisting of SNAP-25, syntaxin-1, and synaptobrevin mediates synaptic vesicle fusion with the presynaptic membrane, releasing neurotransmitter into the synaptic cleft.[1]

Botulinum toxin cleaves SNAP-25 and disrupts SNARE complex formation, preventing neurotransmitter release. Snap-8 and similar peptide compounds were developed as research tools to study SNARE-mediated vesicle fusion by competing with SNAP-25 for complex assembly without enzymatically cleaving the proteins.[2]

Snap-8 is widely used in cosmetic chemistry research, where its proposed mechanism of attenuating muscular contraction signaling has made it a research substrate for non-toxin-based approaches to studying neuromuscular junction biology.[3]

Snap-8 is studied as a research reference compound. It has not been approved by the FDA for any human therapeutic or medical purpose.

Chemistry & Structure

Snap-8 structural features:

  • Sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ (8 residues with N-terminal acetylation and C-terminal amidation)
  • Length: 8 amino acids (octapeptide)
  • N-terminal modification: acetylation
  • C-terminal modification: amidation
  • Source: mimics residues from the N-terminal region of SNAP-25
  • Molecular weight: approximately 1,075 Da

Relationship to Argireline

Snap-8 is closely related to Argireline (Acetyl Hexapeptide-3/8), a 6-amino acid peptide with similar SNARE-disrupting design principles. Snap-8 represents an extended version of the active sequence, with two additional residues at the C-terminus.[3]

Both peptides target the same biological pathway through similar mechanisms — competitive disruption of SNARE complex assembly — though their specific potency and pharmacokinetics differ.

Mechanism Research

Snap-8's research-characterized mechanism is at the SNARE complex.

SNARE complex disruption

Snap-8 competes with native SNAP-25 for incorporation into the SNARE complex during vesicle fusion. By substituting for a portion of the SNAP-25 sequence with the peptide mimetic, the assembled complex is less functional in driving vesicle fusion.[2]

Vesicle fusion assays

Cell-free reconstituted membrane fusion systems are used to characterize Snap-8 effects on SNARE complex function. Liposomes loaded with fluorescent markers serve as quantitative readouts of fusion efficiency.[4]

Neuromuscular signaling research

Preclinical preparations of neuromuscular junctions and isolated neurons examine Snap-8 effects on neurotransmitter release. Endpoints include miniature endplate potential frequency and acetylcholine release quantification.[5]

Documented Preclinical Research Areas

Snap-8 research is concentrated in cosmetic chemistry and SNARE biology.

Cosmetic chemistry research

Skin penetration and dermal absorption studies have characterized Snap-8 behavior in cosmetic-relevant formulations. The compound is among the most-used 'peptide mimetics' in cosmetic chemistry research.[3]

Cell-based SNARE biology

Cell-based studies use Snap-8 as a non-enzymatic tool for partially disrupting SNARE function. This complements toxin-based approaches that fully eliminate SNARE function via proteolytic cleavage.[4]

Comparative peptide research

Snap-8 is studied alongside related compounds (Argireline, other SNARE-mimetic peptides) in comparative studies of structure-activity relationships within this peptide class.[6]

Stability & Handling

Snap-8 is a stable octapeptide with both N- and C-terminal protecting modifications. Standard peptide handling applies.

Storage

Lyophilized material is stored at minus 20 degrees Celsius for long-term preservation. The terminal modifications provide good chemical stability.

Reconstitution

Bacteriostatic water or sterile water are standard reconstitution solvents.

Quality verification

HPLC for purity, mass spectrometry for identity confirmation matching the modified octapeptide mass, and endotoxin screening. Each batch of Instant Peptides Snap-8 ships with a full Certificate of Analysis.

Available Research Material

Instant Peptides supplies Snap-8 as a synthetic lyophilized reference compound in 10mg vials. Material is supplied to qualified research professionals. Not for human or animal consumption.

View the product page for current pricing and the Certificate of Analysis for the active batch.

Available Research Material

Snap-8

Lyophilized synthetic reference compound. Independently tested for purity by HPLC and mass spectrometry. Full Certificate of Analysis included.

View product details

References

  1. 1.Söllner T, Whiteheart SW, Brunner M, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993. PMID: 8455717
  2. 2.Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science. 2002. PMID: 18494906
  3. 3.Wang Y, Wang M, Xiao S, et al. The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide. Clinical Drug Investigation. 2013. PMID: 23818142
  4. 4.Pobbati AV, Stein A, Fasshauer D. N- to C-terminal SNARE complex assembly promotes rapid membrane fusion. Science. 2006. PMID: 16373534
  5. 5.Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992. PMID: 1331807
  6. 6.Ruiz MA, Clares B, Morales ME, et al. Preparation and stability of cosmetic formulations with an anti-aging peptide. Journal of Cosmetic Science. 2007. PMID: 17609830

Related Research